Profound Medical (TSE:PRN) has released an update.
Profound Medical Corp recently held their ‘PRO-Talk Live!’ event, attracting physicians to discuss the TULSA-PRO technology for prostate disease treatment. Key opinion leaders and experts provided insights on using TULSA-PRO, while Siemens Healthineers and Cook Medical endorsed a shared vision with Profound for a comprehensive MR solution in prostate disease management.
For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.
